Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

By sjmartinez • April 15, 2024

Weld ED, McGowan I, Anton P, Fuchs EJ, Ho K, Carballo-Dieguez A, Rohan LC, Giguere R, Brand R, Edick S, Bakshi RP, Parsons T, Manohar M, Seigel A, Engstrom J, Elliott J, Jacobson C, Bagia C, Wang L, Al-Khouja A, Hartman DJ, Bumpus NN, Spiegel HML, Marzinke MA, Hendrix CW. Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01). J Infect Dis. 2024 Apr 12;229(4):1131-1140. doi: 10.1093/infdis/jiad535. PMID: 38019657; PMCID: PMC11011183.

Tags: Digestive Diseases, HIV, Microbicide, Pharmacodynamics, Pharmacokinetics, phase 1, preexposure prophylaxis, Publications

Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical Trial

May FP, Brodney S, Tuan JJ, Syngal S, Chan AT, Glenn B, Johnson G, Chang Y, Drew DA, Moy B, Rodriguez NJ, Warner ET, Anyane-Yeboa[...]

Integrated behavioral care in general hepatology increases alcohol use disorder treatment in veterans

Perumalswami PV, Cornwell BL, Grau PP, Meyers AC, Jayaram M, Irani S, Wongsirisakul P, Liangpunsakul S, Patel A, DePhilippis D, Liberto J, Szymanski BR, McCarthy[...]

Patient-Reported Barriers to On-Time Surveillance After Successful Endoscopic Eradication of Barrett’s Esophagus Neoplasia: A Multicenter Qualitative Interview Study

Kahn A, Paul MM, Kolb JM, Brown B, Eluri S, Leggett CL, Codipilly DC, Ramirez FC, Iyer PG. Patient-Reported Barriers to On-Time Surveillance After Successful[...]